Genelife Clinical Research has devised global capability and seven years of experience in running small molecule clinical trials. From the large companies to the small start-ups, small molecule pharmaceutical companies rely upon our global leadership in phase I-IV studies.
Genelife Clinical Research have close interactions with hundreds of oncology, cardiovascular, CNS, dermatology, gastroenterology, ophthalmology, and other therapeutic area doctors around the globe. These investigators represent small clinics to big hospitals with experience in conducting clinical trials. The selection criterion of these sites use to be recruitment rate and quality evaluation to maintaining the highest quality clinical research procedures as established by FDA, EMEA, DCGI and sponsor’s audits. While developing a clinical trials plan for small molecule, we analyze the specific issues and questions raised by regulators.